Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of MR4 vs Prograf in de Novo Kidney Transplant Recipients
NCT00720265Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2006
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus + Wuzhi capsule in kidney transplant rejection, sponsored by Astellas Pharma. Started Feb 2006; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00720265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720265.